Related Experiment Video
Updated: Jul 6, 2026
05:39
Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Mast cells, TGF-beta1 and alpha-SMA expression in IgA nephropathy
G E B Silva1, R S Costa, R C Ravinal
1Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil.
Disease Markers
|March 13, 2008
Summary
Increased mast cells and alpha-smooth muscle actin (alpha-SMA) in the kidney tubulointerstitium indicate a poor prognosis for IgA nephropathy (IgAN) patients. These markers may predict unfavorable clinical outcomes in IgAN.
Area of Science:
- Nephrology
- Immunopathology
- Renal Pathology
Background:
- IgA nephropathy (IgAN) is a kidney disease with variable prognosis.
- Alpha-smooth muscle actin (alpha-SMA) and transforming growth factor-beta1 (TGF-beta1) expression, along with mast cell infiltration, are potential prognostic markers in renal diseases.
Purpose of the Study:
- To investigate the prognostic value of mast cell, TGF-beta1, and alpha-SMA expression in IgAN patients.
- To correlate these markers with the clinical course and renal prognosis of IgAN.
Main Methods:
- Retrospective analysis of 62 IgAN patients' medical records and renal biopsy reports (1987-2003).
- Immunohistochemical analysis for mast cell tryptase, TGF-beta1, and alpha-SMA.
- Evaluation of clinical course over a mean follow-up of 74.7 months.
Main Results:
- Interstitial mast cell infiltrates and tubulointerstitial alpha-SMA expression were associated with an unfavorable clinical course in IgAN.
- Glomerular TGF-beta1 and alpha-SMA expression, and interstitial TGF-beta1 expression did not correlate with the clinical course.
Conclusions:
- Increased interstitial mast cells and higher tubulointerstitial alpha-SMA expression are potential predictive factors for poor prognosis in IgAN.
- These findings highlight the role of specific cellular and molecular markers in stratifying IgAN patient outcomes.
